Preparation and in Vitro Evaluation of Polylactic Acid (PLA) or Polylactic-co-Glycolic Acid (PLGA) Microcapsules Loaded with Estradiol

Abstract

Abstract: Aim PLA/PLGA was used as biodegradable and biocompatible carriers to achieve sustained release of estradiol (E2). Methods Microcapsules (MC) were prepared by an emulsification-solvent extraction method, and then the properties and in vitro drug release behavior of MC were examined. An analysis of variance (ANOVA) was used to test the statistical significance. Then, multiple comparisons were made with a T-method between levels to examine the significance of difference further. For all the results a P value>0.05 was considered statistically insignificant. Results Under the same conditions, the water-adding speed and the particle size had significant effects (P<0.01) on the entrapment efficiency of MC; the water-adding speed and the concentration of PLA in the oil phase had significant effects (P<0.01) on the diameter MC in medium. Release of E2 from MC was influenced significantly (P<0.01) by the water-adding speed and the type and molecule weight of the polymers. But the differences between levels of the variates were not all significant. Conclusion E2-PLA/PLGA-MC with various properties can be formed when the formulation and the technology were changed accordingly.

Key words: microcapsules, microcapsules, estradiol, estradiol, PLA, PLA, PLGA, PLGA, emulsification solvent extraction, emulsification solvent extraction

CLC Number:

R945

Supporting:

ZHOU Xin-teng^*, ZHU Feng, PAN Wei-san, WANG Lei, ZHANG Ru-hua . Preparation and in Vitro Evaluation of Polylactic Acid (PLA) or Polylactic-co-Glycolic Acid (PLGA) Microcapsules Loaded with Estradiol[J]. .

References

[1] Zheng JM. Textbook of Pharmaceutical Polymers [M]. Beijing: Chinese Medical Technology Press, 1992. 117.
[2] Yasuaki O, Hiroaki O, Masaki Y. In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly (lactic/glycotic) acids and in vivo degradation of these polymers [J]. Chem Pharm Bull, 1988, 36: 2576.
[3] Tae GP. Degradation of poly (lactic-co-glycolic acid) microspheres : effects of copolymers composition [J]. Biomaterials, 1995, 16: 1123-1130.
[4] Atkins TJ, Lewis DH, Rickey ME. An injectable, 30 d naltrexone delivery system [J]. Proc Int Symp Controlled Release Bioact Mater, 1992, 19th: 54-55.
[5] Kobayashi D, Tsubuku S, Yamanaka H, et al. In vivo characteristics of injectable poly (DL-lactic acid) microspheres for long-acting drug delivery [J]. Drug Dev Ind Pharm, 1998, 24 (9): 819-825.
[6] Maria T, Jessica N, Yuyi G, et al. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle [J]. Pharm Res, 1999, 16 (5): 682-688.
[7] Falk RF, Randolph TW. Process variable implication for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly (L-lactide) microparticles [J]. Pharm Res, 1998, 15 (8): 1233-1237.
[8] Benita S, Benoit JP, Puisteux F, et al. Characterization of drug-loaded poly ( d, l-lactide) microspheres [J]. J Pharm Sci, 1984, 73 (12): 1721-1724.
[9] Hiroaki O, Masaki Y, Toshiro H, et al. Drug delivery using biodegradable microspheres [J]. J Controlled Release, 1994, 28: 121-129.
[10] Duane TB, Jacqueline DK, David BH, et al. Controlled release of β-estradiol from PLGA microparticles: the effect of organic phase solvent on encapsulation and release [J]. J Controlled Release, 2000, 65: 375-387.
[11] Hongkee S. Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microcapsules [J]. J Controlled Release, 1997, 47: 233-245.
[12] Zhou XT, Pan WS, Zhang RH, et al. Preparation and evaluation of poly (d,l-lactic acid) (PLA) or d,l-lactide/glycolide copolymer (PLGA) microspheres with estradiol [J]. Die Pharmazie, 2002, 10: 695-697.
[13] Huang ZH and Fang JQ. Mathematical Statistical Methods [M]. Beijing: People’s Health Press, 1990. 141-152.
[14] Manger JW, Chilko D, Howard S. On the analysis of dissolution rate [J]. Drug Dev Ind Pharm, 1986, 12 (7): 969-992.
[15] Joachim H, Roland B. Somatostatin containing biodegradable microcapsules prepared by a modified solvent evaporation method based on w/o/w-multiple emulsion [J]. Int J Pharm,1995, 126: 129-138.